Vendor, Irvine, CA
Vulcan Biologics Inc.
UEI LNBVDMU2KNN5, CAGE 8FEM6
1 award and $299,914 obligated between September 9, 2024 and March 25, 2025, 100% under full and open competition, against 5.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $299,914 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93024C00061Definitive Contract, September 9, 2024, Full and Open Competition After Exclusion of Sources, 5 offers | National Institutes of Health NiaidNational Institutes of Health | SBIR Topic 131 - New Award to Vulcan BiologicsNAICS 541715, PSC AN12 | $299,914 |
- Places of performance
- California
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 2 across 1 awards